Osteoboost Raises $8M To Scale Wearable Targeting Bone Loss in Women
Osteoboost, an FDA-cleared wearable that slowed bone-density loss by 85% in clinical trials, just raised $8 million.
Read More from the Global Wellness News ™
- ONTO Health Raises $20M Series A for AI-Enabled Fertility and Longevity Care; Announces Gulf Region Expansion
- New study: Americans spending more on prevention | Hair care is the new longevity play | European fitness market reaches $45B, with much room to grow